Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00179166 · ClinicalTrials.gov registry record · Phase 2
Assessment of Metabolic Response in Critically Ill Patients With Acute Renal Failure
A Phase 2 study, sponsored by Vanderbilt University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT00179166 is a Phase 2 study that was terminated before completion, run by Vanderbilt University. The registered enrollment target is 3 participants.
The verdict
NCT00179166, a Phase 2 study, was terminated before completion, sponsored by Vanderbilt University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
We hypothesize that a nutritional supplementation with higher than standard protein content (2.0 gm/Kg/day vs 1.4 gm/Kg/day) will result in improved whole-body net protein balance when administered to critically ill patients with acute renal failure (ARF).
Interventions
- DRUG TPN nutritional supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2004-06 |
| Est. Completion | 2005-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00179166
The ClinicalTrials.gov registry entry for NCT00179166 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TPN nutritional supplement is the first listed.
NCT00179166 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00179166 about?
NCT00179166 is a clinical study titled "Assessment of Metabolic Response in Critically Ill Patients With Acute Renal Failure". We hypothesize that a nutritional supplementation with higher than standard protein content (2.0 gm/Kg/day vs 1.4 gm/Kg/day) will result in improved whole-body net protein balance when administered to critically ill patients with acute renal failure (ARF).
What is the current status of trial NCT00179166?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2004-06. Estimated completion is 2005-07.
What interventions are being tested in trial NCT00179166?
The interventions under investigation include: TPN nutritional supplement (DRUG).
Who is sponsoring clinical trial NCT00179166?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.